Compare profiles
Side-by-side leveling, scope, and market pay. Add up to four via ?keys=SWE.GEN.P5,SWE.GEN.P6.
| vs | P3 QUALIT1.QUALITYA4A7C.P3 Quality Assurance - Biotechnology CDMO (GxP/Regulated) — P3 | P2 QUALIT1.QUALITYA4A7C.P2 Quality Assurance - Biotechnology CDMO (GxP/Regulated) — P2 | P4 QUALIT1.QUALITYA4A7C.P4 Quality Assurance - Biotechnology CDMO (GxP/Regulated) — P4 | P3 QUALIT1.QUALITYA898D.P3 Quality Assurance - Life Sciences Robotics — P3 |
|---|---|---|---|---|
| Market pay | $81k ($64k–$103k)inherited | $71k ($56k–$90k)inherited | $107k ($84k–$137k)inherited | $81k ($64k–$103k)inherited |
| Level | P3 · P3 — Mid-Level Professional | P2 · P2 — Developing Professional | P4 · P4 — Senior Professional | P3 · P3 — Mid-Level Professional |
| Function | Quality Assurance | Quality Assurance | Quality Assurance | Quality Assurance |
| Focus | Quality Assurance - Biotechnology CDMO (GxP/Regulated) | Quality Assurance - Biotechnology CDMO (GxP/Regulated) | Quality Assurance - Biotechnology CDMO (GxP/Regulated) | Quality Assurance - Life Sciences Robotics |
| Typical years | 3–5 | 1–3 | 5–8 | 3–5 |
| Scope | Features or a sub-system end-to-end | Defined deliverables / small features | A system or set of related features | Features or a sub-system end-to-end |
| Autonomy | Works independently on standard work; reviewed on the non-standard | General supervision; reviewed at milestones | Self-directed; reviewed at critical decision points | Works independently on standard work; reviewed on the non-standard |
| Impact | Project / team outcomes | Own and immediate-team deliverables | Multi-team / function outcomes | Project / team outcomes |
| Decision rights | Owns implementation decisions for own scope | Routine technical choices within guidance | Owns technical decisions for a system; influences adjacent design | Owns implementation decisions for own scope |